Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status Current. The shortage was first posted on 04/10/2020.
Shortage Details
- Status
- Current
- Company
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Package NDC
- 0781-3494-95
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)
- Initial Posting
- 04/10/2020
- Revised Date